HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells that produces an inflammatory positive feedback loop via astrocytes in HAM/TSP
- PMID: 27542993
- DOI: 10.1016/j.jneuroim.2016.08.012
HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells that produces an inflammatory positive feedback loop via astrocytes in HAM/TSP
Abstract
The main feature of Human T-lymphotropic virus type I (HTLV-1) -associated myelopathy/tropical spastic paraparesis (HAM/TSP) pathogenesis is a virus-induced hyperactive immune response that produces chronic inflammation in the central nervous system (CNS), but the mechanism by which HTLV-1 deregulates the immune response is unknown. We recently reported a high frequency of HTLV-1-infected CCR4+ cells, including regulatory T cells. We showed that HTLV-1 induces a Th1-like state in these CCR4+ cells via T-bet expression. We have also found that CXCL10 plays an important role in a positive feedback loop that maintains inflammation in the CNS. Astrocytes, which were found to be the main producers of CXCL10 in the CNS, are another key player in the loop. In short, we postulate that infected CCR4+ Th1-like T cells produce interferon-γ, which stimulates astrocytes to produce CXCL10. We now have a much better understanding of the molecular mechanisms at play in HAM/TSP pathogenesis.
Keywords: Astrocyte; CCR4; CXCL10; CXCR3; HAM; HTLV-1.
Copyright © 2016 Elsevier B.V. All rights reserved.
Similar articles
-
HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells.J Clin Invest. 2014 Aug;124(8):3431-42. doi: 10.1172/JCI75250. Epub 2014 Jun 24. J Clin Invest. 2014. PMID: 24960164 Free PMC article.
-
[Developing novel treatments for HTLV-1-associated myelopathy (HAM) by investigating molecular pathomechanisms].Nihon Rinsho Meneki Gakkai Kaishi. 2016;39(3):207-12. doi: 10.2177/jsci.39.207. Nihon Rinsho Meneki Gakkai Kaishi. 2016. PMID: 27320936 Review. Japanese.
-
Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy.Brain. 2013 Sep;136(Pt 9):2876-87. doi: 10.1093/brain/awt183. Epub 2013 Jul 26. Brain. 2013. PMID: 23892452
-
Mogamulizumab, an anti-CCR4 antibody, targets human T-lymphotropic virus type 1-infected CD8+ and CD4+ T cells to treat associated myelopathy.J Infect Dis. 2015 Jan 15;211(2):238-48. doi: 10.1093/infdis/jiu438. Epub 2014 Aug 7. J Infect Dis. 2015. PMID: 25104771
-
HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy.Folia Neuropathol. 2009;47(2):182-94. Folia Neuropathol. 2009. PMID: 19618340 Review.
Cited by
-
Following the Clues: Usefulness of Biomarkers of Neuroinflammation and Neurodegeneration in the Investigation of HTLV-1-Associated Myelopathy Progression.Front Immunol. 2021 Oct 26;12:737941. doi: 10.3389/fimmu.2021.737941. eCollection 2021. Front Immunol. 2021. PMID: 34764955 Free PMC article.
-
Identification of hub genes and molecular pathways in human T-lymphotropic virus type 1 associated diseases using protein-protein interactions networks.Iran J Microbiol. 2022 Feb;14(1):125-132. doi: 10.18502/ijm.v14i1.8814. Iran J Microbiol. 2022. PMID: 35664724 Free PMC article.
-
Retroviral b-Zip protein (HBZ) contributes to the release of soluble and exosomal immune checkpoint molecules in the context of neuroinflammation.J Extracell Biol. 2023 Jul;2(7):e102. doi: 10.1002/jex2.102. Epub 2023 Jul 17. J Extracell Biol. 2023. PMID: 37547182 Free PMC article.
-
HTLV-1, the Other Pathogenic Yet Neglected Human Retrovirus: From Transmission to Therapeutic Treatment.Viruses. 2017 Dec 21;10(1):1. doi: 10.3390/v10010001. Viruses. 2017. PMID: 29267225 Free PMC article. Review.
-
Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.Retrovirology. 2019 Aug 22;16(1):23. doi: 10.1186/s12977-019-0484-z. Retrovirology. 2019. PMID: 31438973 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous